PERIPHERAL NERVE STIMULATOR NS252AUU

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06,08 report with the FDA on 2008-06-12 for PERIPHERAL NERVE STIMULATOR NS252AUU manufactured by Fisher & Paykel Healthcare, Ltd..

Event Text Entries

[872342] A healthcare facility in another country, reported that a pt got a minor burn while the peripheral nerve stimulator was being used.
Patient Sequence No: 1, Text Type: D, B5


[8067482] An investigation will be carried out once we receive the complaint device. A follow up report will be provided.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number9611451-2008-00365
MDR Report Key1059824
Report Source01,05,06,08
Date Received2008-06-12
Date of Report2008-05-20
Date Mfgr Received2008-05-20
Date Added to Maude2009-06-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactGORDON RICHMAN
Manufacturer Street15365 BARRANCA PKWY
Manufacturer CityIRVINE CA 926182216
Manufacturer CountryUS
Manufacturer Postal926182216
Manufacturer Phone9494534000
Manufacturer G1FISHER & PAYKEL HEALTHCARE, LTD.
Manufacturer Street15 MAURICE PAYKEL PLACE
Manufacturer CityEAST TAMAKI, AUCKLAND
Manufacturer CountryNZ
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePERIPHERAL NERVE STIMULATOR
Product CodeBXN
Date Received2008-06-12
Model NumberNS252AUU
Catalog NumberNS252AUU
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerFISHER & PAYKEL HEALTHCARE, LTD.
Manufacturer AddressAUCKLAND NZ


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2008-06-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.